Finally, resistant Nlrp1bS-expressing mice treated daily with the human IL-1 receptor antagonist anakinra (shown to be effective in rodents [28]–[30]), were sensitized to infection (Fig. 5D), confirming a role for IL-1 signaling in resistance to infection. Here, IL1B is linked to infection.